BioSpace News Archive

The use of metabolomic constellations instead of individual biomarkers is becoming more and more the focus of in-vitro diagnostics in order to provide information to the treating physicians for diagnostic questions which have not yet been clarified.

Apollo Endosurgery announced today it has entered into a Registry Funding Agreement with the American Gastroenterological Association (AGA) Center for GI Innovation and Technology to develop and administer a registry to evaluate flexible endoscopic procedures enabled by the OverStitch™ Endoscopic Suturing System.

Bayer announced today that data from its pulmonary disease franchise will be presented in scientific sessions at the 2017 annual meeting of the American College of Chest Physicians (CHEST 2017), October 28 - November 1 in Toronto, Canada.

A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicinefound that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes when compared to youths who formerly used (but eventually discontinued) those medications.

Microsoft Corp. and PAREXEL International Corp., a leading global biopharmaceutical services organization, on Tuesday announced a technology development alliance aimed at driving innovation across the life sciences industry with technology powered by Microsoft Azure.

TGaS Advisors announced the promotion of Curt Staab to Senior Vice President, Emerging Life Sciences Network (elsN). A division of TGaS, elsN is a membership organization for emerging and pre-commercial life sciences companies.

MorphoSys AG announced today that FDA has granted Breakthrough Therapy designation to MOR208, in combination with lenalidomide, for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).

Pulse Biosciences, Inc. announced it will host its quarterly investor conference call on Tuesday, November 7, 2017 at 1:30 p.m. PST / 4:30 p.m. EST.